Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The online launch event of the SAFE project “Supporting At-risk researchers with Fellowships in Europe” aims to inform potential host institutions in the EU, as well as doctoral and postdoctoral researchers at risk from any non-EU nationality about the call for application which will be launched on 18 November 2024 and close on 20 January 2025. Registrations for the webinar are possible until 18 November through this Zoom link.
What is the call for applications of the SAFE project about?
The SAFE project will provide up to 60 fellowships to non-EU at-risk researchers from all over the world for a research stay at a European higher education and research institution for a minimum of 12 months up to 24 months.
The terms of reference (download) provide information on the fellowship scheme, the eligibility criteria, the application requirements, and the evaluation process.
The SAFE project team has developed an eligibility and risk questionnaire to assist potential host institutions in assessing the eligibility and risk of candidate-researchers. Institutions are strongly encouraged to make use of this tool before considering handing in an application.
Applications have to be submitted by the potential host organisations, and not by the individual researchers themselves. The same host institution can send one application on behalf of one researcher only. For any inquiries regarding the application process contact info.safe@daad.de.
The SAFE project offers a matchmaking service providing support for researchers at risk on the one hand, by connecting them with a host institution in the EU and for potential host institutions on the other hand, by assisting them in finding a researcher that fits their hosting offer, with the aim of developing a joint proposal for the call for applications. The matchmaking service will be available until mid-December 2024. For any further information on the matchmaking service contact info.safe@uni-med.net.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Agro-Food, Environment Missions
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.